DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ilaris (Canakinumab) - Concomitant Disease Progression - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Concomitant Disease Progression (13)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Ilaris (Canakinumab) where reactions include concomitant disease progression. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Ilaris side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-29

Patient: male, weighing 113.2 kg (249.0 pounds)

Reactions: Unresponsive To Stimuli, Haemorrhage Intracranial, Cerebral Artery Occlusion, Cerebrovascular Accident, Concomitant Disease Progression, Convulsion, Speech Disorder, Hypoaesthesia Oral, Amyloidosis, Brain Oedema, Respiration Abnormal

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Ilaris

Other drugs received by patient: Keppra



Possible Ilaris side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-20

Patient: male, weighing 116.1 kg (255.4 pounds)

Reactions: Delirium, Concomitant Disease Progression

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ilaris
    Dosage: double-blind
    Start date: 2011-06-02

Triamcinolone Acetonide
    Dosage: double-blind
    Indication: Gouty Arthritis
    Start date: 2011-06-02

Furosemide
    Dosage: 80 mg, qd
    Administration route: Oral
    Indication: Oedema
    Start date: 2010-03-17

Placebo
    Dosage: double-blind
    Indication: Gouty Arthritis
    Start date: 2011-06-02

Ilaris
    Dosage: double-blind
    Indication: Gouty Arthritis
    Start date: 2011-06-02

Blinded NO Treatment Received
    Dosage: double-blind
    Indication: Gouty Arthritis
    Start date: 2011-06-02

Other drugs received by patient: Plavix; Triamcinolone; Metoprolol Tartrate; Tramadol HCL; Januvia; Acarbose; Simvastatin; Colchicine; Cardura; Nitroglycerin; Fexofenadine; Lutein; Catapres-TTS-2; Proscar; Omeprazole



Possible Ilaris side effects in female

Reported by a physician from United States on 2012-05-15

Patient: female, weighing 90.3 kg (198.7 pounds)

Reactions: Overdose, Palpitations, Angina Unstable, Suicide Attempt, Concomitant Disease Progression, Suicidal Ideation

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Blinded NO Treatment Received
    Dosage: double blinded
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-06-23

Klonopin
    Dosage: weekly
    Indication: Anxiety
    Start date: 2011-08-18

Metoprolol Succinate Extended Release
    Dosage: 50 mg, bid
    Administration route: Oral
    Start date: 2012-05-01

Placebo
    Dosage: double blinded
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-06-23

Metoprolol Succinate Extended Release
    Dosage: 25 mg, bid
    Administration route: Oral
    Start date: 2011-06-17
    End date: 2012-04-30

Ilaris
    Dosage: double blinded
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-06-23

Other drugs received by patient: Trazodone HCL; Buspar; Aspirin; Trazodone HCL; Effexor; Effexor; Effexor; Effexor; Buspar



Possible Ilaris side effects in male

Reported by a physician from Germany on 2012-05-09

Patient: male, weighing 126.9 kg (279.2 pounds)

Reactions: Gouty Arthritis, Diabetic Foot Infection, Concomitant Disease Progression, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ilaris
    Dosage: code not broken
    Indication: Arteriosclerosis
    Start date: 2011-03-31

Placebo
    Dosage: code not broken
    Indication: Arteriosclerosis
    Start date: 2011-03-31

Other drugs received by patient: Levemir; Cymbalta; Ebrantil; Metoprolol Tartrate; Novorapid; Aspirin; Clopidogrel; Metoprolol Tartrate; Simvastatin; Torsemide; Aprovel



Possible Ilaris side effects in female

Reported by a physician from United States on 2012-05-08

Patient: female, weighing 90.3 kg (198.7 pounds)

Reactions: Overdose, Palpitations, Angina Unstable, Suicide Attempt, Concomitant Disease Progression, Suicidal Ideation

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Klonopin
    Dosage: weekly
    Indication: Anxiety
    Start date: 2011-08-18

Placebo
    Dosage: double blinded
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-06-23

Ilaris
    Dosage: double blinded
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-06-23

Blinded NO Treatment Received
    Dosage: double blinded
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-06-23

Metoprolol Succinate Extended Release
    Dosage: 25 mg, bid
    Administration route: Oral
    Start date: 2011-06-17
    End date: 2012-04-30

Metoprolol Succinate Extended Release
    Dosage: 50 mg, bid
    Administration route: Oral
    Start date: 2012-05-01

Other drugs received by patient: Buspar; Buspar; Effexor; Effexor; Trazodone HCL; Aspirin; Effexor



Possible Ilaris side effects in female

Reported by a physician from United States on 2012-03-23

Patient: female, weighing 84.6 kg (186.1 pounds)

Reactions: Pneumonia, Haemoptysis, Concomitant Disease Progression

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Blinded Placebo
    Dosage: code not broken
    Administration route: Oral
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-09-06

Ilaris
    Dosage: code not broken
    Administration route: Oral
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-09-06

Blinded NO Treatment Received
    Dosage: code not broken
    Administration route: Oral
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-09-06

Other drugs received by patient: Lisinopril; Lisinopril; Fenofibrate; Carvedilol; Simvastatin; Aspirin; Plavix; Carvedilol



Possible Ilaris side effects in male

Reported by a physician from Germany on 2012-02-28

Patient: male, weighing 126.9 kg (279.2 pounds)

Reactions: Gouty Arthritis, Diabetic Foot Infection, Concomitant Disease Progression, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ilaris
    Dosage: double blinded
    Indication: Arteriosclerosis
    Start date: 2011-03-31

Blinded Placebo
    Dosage: double blinded
    Indication: Arteriosclerosis
    Start date: 2011-03-31

Other drugs received by patient: Irbesartan; Ebrantil; Metoprolol Tartrate; Novorapid; Torsemide; Simvastatin; Metoprolol Tartrate; Levemir; Aspirin; Clopidogrel; Cymbalta



Possible Ilaris side effects in female

Reported by a physician from United States on 2012-02-24

Patient: female, weighing 84.6 kg (186.1 pounds)

Reactions: Pneumonia, Haemoptysis, Concomitant Disease Progression

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Blinded Placebo
    Dosage: code not broken
    Administration route: Oral
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-09-06

Blinded NO Treatment Received
    Dosage: code not broken
    Administration route: Oral
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-09-06

Ilaris
    Dosage: code not broken
    Administration route: Oral
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-09-06

Other drugs received by patient: Aspirin; Fenofibrate; Lisinopril; Plavix; Carvedilol; Lisinopril; Simvastatin; Carvedilol



Possible Ilaris side effects in male

Reported by a physician from Italy on 2012-02-17

Patient: male, weighing 77.7 kg (170.9 pounds)

Reactions: Pneumonia, Anaemia, Condition Aggravated, Concomitant Disease Progression

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ilaris
    Dosage: double blinded
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2012-01-17

Blinded NO Treatment Received
    Dosage: double blinded
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2012-01-17

Placebo
    Dosage: double blinded
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2012-01-17

Warfarin
    Dosage: unk
    Start date: 2011-04-29

Other drugs received by patient: Aspirin; Furosemide; Nitroglycerin; Ramipril



Possible Ilaris side effects in male

Reported by a physician from Germany on 2012-02-03

Patient: male, weighing 126.9 kg (279.2 pounds)

Reactions: Gouty Tophus, Diabetic Foot Infection, Concomitant Disease Progression

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ilaris
    Dosage: blinded
    Indication: Arteriosclerosis
    Start date: 2011-03-31

Placebo
    Dosage: blinded
    Indication: Arteriosclerosis
    Start date: 2011-03-31

Other drugs received by patient: Levemir; Novorapid; Irbesartan; Ebrantil; Metoprolol; Metoprolol; Clopidogrel; Simvastatin; Torsemide; Aspirin; Cymbalta



Possible Ilaris side effects in male

Reported by a physician from United States on 2012-02-03

Patient: male, weighing 108.0 kg (237.6 pounds)

Reactions: Concomitant Disease Progression, Epistaxis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Naproxen
    Dosage: double blind
    Indication: Osteoarthritis

Omeprazole
    Dosage: double blind
    Indication: Osteoarthritis

Ilaris
    Dosage: double blind
    Indication: Osteoarthritis

Blinded NO Treatment Received
    Dosage: double blind
    Indication: Osteoarthritis

Other drugs received by patient: Methotrexate



Possible Ilaris side effects in female

Reported by a physician from United States on 2012-01-20

Patient: female, weighing 90.3 kg (198.7 pounds)

Reactions: Overdose, Suicide Attempt, Concomitant Disease Progression

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Klonopin
    Dosage: weekly
    Indication: Anxiety
    Start date: 2011-08-18

Metoprolol Succinate Extended Release

Ilaris
    Dosage: double blinded
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-06-23

Blinded NO Treatment Received
    Dosage: double blinded
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-06-23

Blinded Placebo
    Dosage: double blinded
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-06-23

Other drugs received by patient: Effexor; Effexor; Effexor



Possible Ilaris side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-05

Patient: female, weighing 90.3 kg (198.7 pounds)

Reactions: Overdose, Suicide Attempt, Concomitant Disease Progression

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Ilaris
    Dosage: double blinded
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-06-23

Blinded NO Treatment Received
    Dosage: double blinded
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-06-23

Metoprolol Succinate Extended Release

Placebo
    Dosage: double blinded
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-06-23

Klonopin
    Dosage: weekly
    Indication: Anxiety
    Start date: 2011-08-18

Other drugs received by patient: Effexor; Effexor

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017